Literature DB >> 19759272

Impaired TGF-beta signalling enhances peritoneal inflammation induced by E. coli in rats.

Xin Wang1, Jing Nie, Zhanjun Jia, Mingliang Feng, Zhihua Zheng, Wenfang Chen, Xiaoyan Li, Wenxing Peng, Shehong Zhang, Liao Sun, Haiping Mao, Hui Yao Lan, Xueqing Yu.   

Abstract

BACKGROUND: Peritonitis is a common and severe complication of peritoneal dialysis (PD). Although TGF-beta is a key mediator in peritoneal fibrosis with chronic PD, its role in acute peritoneal inflammation remains unclear.
METHODS: Potential role of TGF-beta signalling in acute peritonitis was investigated in a rat model by infecting peritoneum with E. coli and in primary culture of peritoneal mesothelial cells (PMC) by LPS.
RESULTS: We found that a single infection of E. coli caused an acute, but transient peritonitis by a significant increase in ascites white blood cells (WBC), peritoneal CD45+ leukocytes, upregulation of TNFalpha, activation of NF-kappaB/p65 and impaired peritoneal function (all P < 0.01). Interestingly, spontaneous recovery of acute peritonitis occurred with upregulation of TGF-beta1 and activation of Smad2/3, suggesting a protective role of TGF-beta signalling in acute peritonitis. This was demonstrated by the finding that blockade of the TGF-beta signalling pathway with gene transfer of Smad7 inactivated peritoneal Smad2/3 but worsened E. coli-induced, NF-kappaB-dependent peritoneal inflammation and peritoneal dysfunction (all P < 0.01). Furthermore, studies in vitro also found that impaired TGF-beta signalling by overexpressing Smad7 in PMC were able to overcome the inhibitory effect of TGF-beta on LPS-induced, NF-kappaB-mediated peritoneal inflammation.
CONCLUSION: Results from this study demonstrate that TGF-beta signalling is essential in protection against acute peritoneal inflammation induced by bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759272     DOI: 10.1093/ndt/gfp480

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis.

Authors:  H Yoshizawa; Y Morishita; M Watanabe; K Ishibashi; S Muto; E Kusano; D Nagata
Journal:  Gene Ther       Date:  2015-01-08       Impact factor: 5.250

Review 2.  Management of a rapidly growing peritoneal dialysis population at the First Affiliated Hospital of Sun Yat-sen University.

Authors:  Xueqing Yu; Xiao Yang; Naya Huang
Journal:  Perit Dial Int       Date:  2014-06       Impact factor: 1.756

3.  Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.

Authors:  Jesús Loureiro; Abelardo Aguilera; Rafael Selgas; Pilar Sandoval; Patricia Albar-Vizcaíno; María Luisa Pérez-Lozano; Vicente Ruiz-Carpio; Pedro L Majano; Santiago Lamas; Fernando Rodríguez-Pascual; Francisco Borras-Cuesta; Javier Dotor; Manuel López-Cabrera
Journal:  J Am Soc Nephrol       Date:  2011-07-08       Impact factor: 10.121

4.  Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.

Authors:  Elerson C Costalonga; Luiza J de Freitas; Deise da S P Aragone; Filipe M O Silva; Irene L Noronha
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

5.  Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.

Authors:  Alferso C Abrahams; Sayed M Habib; Amélie Dendooven; Bruce L Riser; Jan Willem van der Veer; Raechel J Toorop; Michiel G H Betjes; Marianne C Verhaar; Christopher J E Watson; Tri Q Nguyen; Walther H Boer
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 6.  The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.

Authors:  Angela Rynne-Vidal; José Antonio Jiménez-Heffernan; Concepción Fernández-Chacón; Manuel López-Cabrera; Pilar Sandoval
Journal:  Cancers (Basel)       Date:  2015-09-29       Impact factor: 6.639

7.  miRNA589 regulates epithelial-mesenchymal transition in human peritoneal mesothelial cells.

Authors:  Ke Zhang; Hao Zhang; Xun Zhou; Wen-bin Tang; Li Xiao; Ying-hong Liu; Hong Liu; You-ming Peng; Lin Sun; Fu-you Liu
Journal:  J Biomed Biotechnol       Date:  2012-10-03

Review 8.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

Review 9.  Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.

Authors:  Manuel López-Cabrera
Journal:  Adv Med       Date:  2014-01-23

10.  Preliminary Research of Relationship between Acute Peritonitis and Celiac Primo Vessels.

Authors:  Xiaoyu Wang; Hong Shi; Jingjing Cui; Wanzhu Bai; Wei He; Hongyan Shang; Yangshuai Su; Juanjuan Xin; Xianghong Jing; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.